MECHANISMS OF ANTIMICROBIAL RESISTANCE IN ANAEROBIC-BACTERIA - THE PREDICTIVE APPROACH
- 1 January 1989
- journal article
- research article
- Vol. 62, 25-28
Abstract
Antibiotic resistance in anaerobic bacteria probably evolves from broadly undetected mechanisms of resistance, as the generally accepted breakpoints in susceptibility testing are mainly based on pharmacological grounds. Some of the strains considered susceptible by conventional techniques may harbour mechanisms of resistance. These resistant organisms should be screened using the antibiotic concentrations immediately above those inhibiting the fully susceptible population of a given species as breakpoints. The following break-points for Bacteroides strains are suggested as definitions of the entirely susceptible population: piperacillin 8 mg/l; ceftizoxime 8 mg/l; cefoxitin 8-16 mg/l; imipenem 1 mg/l; ticarcillin-clavulanate 2 mg/l; clindamycin 1 mg/l; chloramphenicol 8 mg/l; tetracycline 4 mg/l; metronidazole 1 mg/l. Detection of an increased frequency of organisms presenting low-level resistance may be useful to predict and possibly control the appearance and spread of fully resistant anaerobic organisms.This publication has 6 references indexed in Scilit:
- Emergence of fluoroquinolone resistance in Bacteroides fragilis accompanied by resistance to beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1988
- Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolationAntimicrobial Agents and Chemotherapy, 1988
- National Committee for Clinical Laboratory Standards agar dilution susceptibility testing of anaerobic gram-negative bacteriaAntimicrobial Agents and Chemotherapy, 1988
- Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides speciesAntimicrobial Agents and Chemotherapy, 1987
- Inducible macrolides-lincosamides-streptogramin B resistance in Bacteroides speciesAntimicrobial Agents and Chemotherapy, 1987
- Cephamycin inactivation due to enzymatic hydrolysis by beta-lactamase from Bacteroides fragilisAntimicrobial Agents and Chemotherapy, 1985